Quest Diagnostics 2003 Annual Report Download - page 46

Download and view the complete annual report

Please find page 46 of the 2003 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 109

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109

Item 15. Exhibits, Financial Statement Schedules and Reports on Form 8-K
(a) Documents filed as part of this report:
1. Index to financial statements and supplementary data filed as part of this report:
Item Page
Report of Independent Auditors ........................................... F-1
Consolidated Balance Sheets .............................................. F-2
Consolidated Statements of Operations ..................................... F-3
Consolidated Statements of Cash Flows .................................... F-4
Consolidated Statements of Stockholders’ Equity ........................... F-5
Notes to Consolidated Financial Statements ................................ F-6
Supplementary Data: Quarterly Operating Results (unaudited)................ F-36
2. Financial Statement Schedule:
Item Page
Schedule II—Valuation Accounts and Reserves ............................. F-37
3. Exhibits filed as part of this report:
See (c) below.
(b) Report on Form 8-K filed during the fourth quarter of 2003:
On October 21, 2003, the Company furnished a current report on Form 8-K reporting under Item 7 its
press release of October 31, 2003 announcing, among other things, its results for the quarter and nine
months ended September 30, 2003 and its press release announcing a quarterly cash dividend and the
expansion of the Company’s share repurchase program.
On October 31, 2003, the Company filed a current report on Form 8-K reporting under Item 5 operating
income for the quarters ended March 31, 2003, June 30, 2003 and September 30, 2003 and the nine
months ended September 30, 2003 and for the quarters ended March 31, 2002, June 30, 2002,
September 30, 2002 and December 31, 2002 and the year ended December 31, 2002 on a basis consistent
with the preparation of the Quarterly Report on Form 10-Q for the quarter ended September 30, 2003.
On November 20, 2003, the Company filed an amended current report on Form 8-K (Date of Report:
February 26, 2003) reporting under Item 2 on the acquisition of the outstanding capital stock of Unilab
Corporation.
(c) Exhibits filed as part of this report:
Exhibit
Number Description
3.1 Restated Certificate of Incorporation (filed as an Exhibit to the Company’s current report on
Form 8-K (Date of Report: May 31, 2001) and incorporated herein by reference)
3.2 Amended and Restated By-Laws of the Registrant (filed as an Exhibit to the Company’s 2000
annual report on Form 10-K and incorporated herein by reference)
4.1 Form of Rights Agreement dated December 31, 1996 (the “Rights Agreement’’) between Corning
Clinical Laboratories Inc. and Harris Trust and Savings Bank as Rights Agent (filed as an Exhibit
to the Company’s Registration Statement on Form 10 (File No. 1-12215) and incorporated herein
by reference)
4.2 Form of Amendment No. 1 effective as of July 1, 1999 to the Rights Agreement (filed as an
Exhibit to the Company’s current report on Form 8-K (Date of Report: August 16, 1999) and
incorporated herein by reference)
4.3 Form of Amendment No. 2 to the Rights Agreement (filed as an Exhibit to the Company’s 1999
annual report on Form 10-K and incorporated herein by reference)
4.4 Form of Amendment No. 3 to the Rights Agreement (filed as an Exhibit to the Company’s 2000
annual report on Form 10-K and incorporated herein by reference)
4.5 Form of Acceptance by National City Bank as successor Rights Agent under the Rights
Agreement
29